ArticleNPJ vaccines2022

Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population.

Nawamin Pinpathomrat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.